Related Experiment Video
Updated: Jul 4, 2025

Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
Circulating ketone bodies and mortality in heart failure: a community cohort study
Rebecca O Oyetoro1, Katherine M Conners1, Jungnam Joo2
1Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States.
Insights
Ketone bodies (KB) are linked to increased mortality risk in heart failure (HF) patients, especially those with preserved ejection fraction. This study clarifies KB distribution and its association with HF progression and survival outcomes.
Area of Science:
- Cardiology
- Metabolic Research
- Clinical Investigation
Background:
- The prognostic significance of ketone bodies (KB) in heart failure (HF) remains unclear.
- Understanding KB levels can offer new insights into HF pathophysiology and patient outcomes.
Purpose of the Study:
- To determine KB distribution in a heart failure cohort.
- To identify clinical factors associated with KB levels.
- To investigate the relationship between plasma KB and all-cause mortality in HF patients.
Main Methods:
- Plasma KB levels were quantified using nuclear magnetic resonance spectroscopy.
- Multivariable linear regression analyzed associations between clinical factors and KB.
- Proportional hazard regression assessed the link between KB and mortality, adjusting for covariates.
Main Results:
- Higher KB levels correlated with advanced HF (NYHA class III-IV) and elevated NT-proBNP.
- Increased KB levels were independently associated with a higher risk of all-cause mortality (HR 1.23).
- This association was more pronounced in patients with preserved ejection fraction.
Conclusions:
- Most heart failure patients had KB levels comparable to healthy individuals, but elevated levels indicated advanced disease.
- Higher ketone body levels signify an increased mortality risk in heart failure, particularly in the preserved ejection fraction subgroup.
Background:
The relationship between ketone bodies (KB) and mortality in patients with heart failure (HF) syndrome has not been well established.
Objectives:
The aim of this study is to assess the distribution of KB in HF, identify clinical correlates, and examine the associations between plasma KB and all-cause mortality in a population-based HF cohort.
Methods:
The plasma KB levels were measured by nuclear magnetic resonance spectroscopy. Multivariable linear regression was used to examine associations between clinical correlates and KB levels. Proportional hazard regression was employed to examine associations between KB (represented as both continuous and categorical variables) and mortality, with adjustment for several clinical covariates.
Results:
Among the 1,382 HF patients with KB measurements, the median (IQR) age was 78 (68, 84) and 52% were men. The median (IQR) KB was found to be 180 (134, 308) microM. Higher KB levels were associated with advanced HF (NYHA class III-IV) and higher NT-proBNP levels (both P < 0.001). The median follow-up was 13.9 years, and the 5-year mortality rate was 51.8% [95% confidence interval (CI): 49.1%-54.4%]. The risk of death increased when KB levels were higher (HRhigh vs. low group 1.23; 95% CI: 1.05-1.44), independently of a validated clinical risk score. The association between higher KB and mortality differed by ejection fraction (EF) and was noticeably stronger among patients with preserved EF.
Conclusions:
Most patients with HF exhibited KB levels that were consistent with those found in healthy adults. Elevated levels of KB were observed in patients with advanced HF. Higher KB levels were found to be associated with an increased risk of death, particularly in patients with preserved EF.
More Related Videos
03:42Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pathophysiology of Heart Failure
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Metabolic States of the Body: Fasting and Starvation